SCHEMBL3272399

SCHEMBL3272399

O=C(O)[C@H](CO)N(Cc1ccccc1)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
ALDH1A1 P00352 3/20 0.44
GLA P06280 1/20 0.44
HTT P42858 1/20 0.44
PAX8 Q06710 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
CYP1A2 P05177 1/20 0.40
PTPN1 P18031 1/20 0.40
TRPM8 Q7Z2W7 1/20 0.40
ESR1 P03372 1/20 0.40
CRHBP P24387 1/20 0.40
CRHR2 Q13324 1/20 0.40
CA12 O43570 1/20 0.40
CA9 Q16790 1/20 0.40
LMNA P02545 3/20 0.39
POLB P06746 1/20 0.39
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5819566 0.85 CPA3 (0.46) NPC1RAB9AALDH1A1GLAHTT
SCHEMBL5819570 0.85 CPA3 (0.46) NPC1RAB9AALDH1A1GLAHTT
SCHEMBL16858005 0.84 SMPD2 (0.39) NPC1RAB9AALDH1A1GLAHTT
SCHEMBL28654510 0.82 LMNA (0.42) NPC1RAB9AALDH1A1GLAHTT
SCHEMBL30401308 0.81 TSHR (0.47) NPC1RAB9AALDH1A1GLASMN1; SMN2
SCHEMBL27779216 0.81 SMPD2 (0.38) NPC1RAB9AALDH1A1GLAHTT
SCHEMBL11189169 0.80 NPC1 (0.47) NPC1RAB9AALDH1A1GLAHTT
SCHEMBL2855957 0.80 KMT2A (0.49) NPC1RAB9AALDH1A1MEN1KMT2A
SCHEMBL3126212 0.80 KMT2A (0.49) NPC1RAB9AALDH1A1MEN1KMT2A
SCHEMBL3126205 0.80 KMT2A (0.49) NPC1RAB9AALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7687435-B2 Benzoyl-substituted phenylalanineamides BASF AKTIENGESELLSCHAFT (DE) 2010-03-30 US disclosed
US-20070142230-A1 Benzoyl-substituted phenylalanineamides BASF AKTIENGESELLSCHAFT (DE) 2007-06-21 US disclosed
US-20070060480-A1 Heteroaroyl-substituted phenylalanineamides BASF AKTIENGESELLSCHAFT (DE) 2007-03-15 US disclosed
EP-0079390-B1 PROCESS FOR PREPARING BETA-HYDROXY AMINO ACID MITSUI TOATSU CHEMICALS, Inc. (JP) 1985-12-27 EP disclosed
EP-0079390-A1 PROCESS FOR PREPARING BETA-HYDROXY AMINO ACID MITSUI TOATSU CHEMICALS, Inc. (JP) 1983-05-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142230-A1 Benzoyl-substituted phenylalanineamides PAH, TYR, BCAT2 NPC1 3822/4885RAB9A 2967/4885ALDH1A1 1239/4885
US-20070060480-A1 Heteroaroyl-substituted phenylalanineamides PAH, PM20D2, FARSA NPC1 4345/4885RAB9A 1587/4885ALDH1A1 2661/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.